Literature DB >> 11841540

Role of zyxin in differential cell spreading and proliferation of melanoma cells and melanocytes.

Ellen J van der Gaag1, Marie-Thérèse Leccia, Sybren K Dekker, Nicole L Jalbert, Dana M Amodeo, H Randolph Byers.   

Abstract

Cell spreading, proliferation, and survival are modulated by focal adhesions linking extracellular matrix proteins, integrins, and the cytoskeleton. Zyxin is a focal-adhesion-associated phosphoprotein with one domain involved in the control of actin assembly and three protein-protein adapter domains implicated in the regulation of cell growth and differentiation. We characterized zyxin expression in normal human melanocytes and six melanoma cell lines in relation to cell spreading, growth, and differentiation using Western immunoblotting techniques, image analysis, flow cytometry, and confocal microscopy. We found that zyxin, focal adhesion kinase, and paxillin were significantly upregulated in melanoma cells compared to melanocytes. Zyxin expression directly related to cell spreading and proliferation and inversely related to differentiation, whereas focal adhesion kinase correlated only to cell spreading and paxillin did not significantly correlate with any of the parameters. Treatment of melanoma cells with 12-O-tetradecanoylphorbol-13-acetate downregulated zyxin expression, inhibited cell spreading and proliferation, and promoted differentiation. In contrast, 12-O-tetradecanoylphorbol-13-acetate, a mitogen for melanocytes, induced upregulation of zyxin expression in melanocytes. These findings are consistent with a role of zyxin in modulation of cell spreading, proliferation, and differentiation. Therapies directed at the downregulation of this focal adhesion phosphoprotein in melanoma cells implicate a new approach for controlling melanoma cell growth.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11841540     DOI: 10.1046/j.0022-202x.2001.01657.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  11 in total

1.  A compressed sensing based approach for subtyping of leukemia from gene expression data.

Authors:  Wenlong Tang; Hongbao Cao; Junbo Duan; Yu-Ping Wang
Journal:  J Bioinform Comput Biol       Date:  2011-10       Impact factor: 1.122

2.  The Wilms' tumor suppressor WT1 is associated with melanoma proliferation.

Authors:  Nicole Wagner; John Panelos; Daniela Massi; Kay-Dietrich Wagner
Journal:  Pflugers Arch       Date:  2007-10-03       Impact factor: 3.657

3.  Global transcriptomic analysis of model human cell lines exposed to surface-modified gold nanoparticles: the effect of surface chemistry.

Authors:  E M Grzincic; J A Yang; J Drnevich; P Falagan-Lotsch; C J Murphy
Journal:  Nanoscale       Date:  2015-01-28       Impact factor: 7.790

4.  Accurate molecular classification of cancer using simple rules.

Authors:  Xiaosheng Wang; Osamu Gotoh
Journal:  BMC Med Genomics       Date:  2009-10-30       Impact factor: 3.063

5.  Temporal profiling of the adipocyte proteome during differentiation using a five-plex SILAC based strategy.

Authors:  Henrik Molina; Yi Yang; Travis Ruch; Jae-Woo Kim; Peter Mortensen; Tamara Otto; Anuradha Nalli; Qi-Qun Tang; M Daniel Lane; Raghothama Chaerkady; Akhilesh Pandey
Journal:  J Proteome Res       Date:  2009-01       Impact factor: 4.466

6.  Zyxin (ZYX) promotes invasion and acts as a biomarker for aggressive phenotypes of human glioblastoma multiforme.

Authors:  Xian-Mei Wen; Tao Luo; Yi Jiang; Li-Hong Wang; Ying Luo; Qian Chen; Kaidi Yang; Ye Yuan; Chunhua Luo; Xiang Zhang; Ze-Xuan Yan; Wen-Juan Fu; Yu-Huan Tan; Qin Niu; Jing-Fang Xiao; Lu Chen; Jiao Wang; Jia-Feng Huang; You-Hong Cui; Xia Zhang; Yan Wang; Xiu-Wu Bian
Journal:  Lab Invest       Date:  2020-01-16       Impact factor: 5.662

Review 7.  The role of zyxin in regulation of malignancies.

Authors:  Ahmed Kotb; Matthew Eric Hyndman; Trushar R Patel
Journal:  Heliyon       Date:  2018-07-18

8.  PPARbeta activation inhibits melanoma cell proliferation involving repression of the Wilms' tumour suppressor WT1.

Authors:  Jean-François Michiels; Christophe Perrin; Nathalie Leccia; Daniela Massi; Paul Grimaldi; Nicole Wagner
Journal:  Pflugers Arch       Date:  2010-01-12       Impact factor: 3.657

9.  A synthetic, xeno-free peptide surface for expansion and directed differentiation of human induced pluripotent stem cells.

Authors:  Sha Jin; Huantong Yao; Jennifer L Weber; Zara K Melkoumian; Kaiming Ye
Journal:  PLoS One       Date:  2012-11-30       Impact factor: 3.240

10.  Delineating the Tes Interaction Site in Zyxin and Studying Cellular Effects of Its Disruption.

Authors:  Ermin Hadzic; Marie Catillon; Aliaksandr Halavatyi; Sandrine Medves; Marleen Van Troys; Michèle Moes; Michelle A Baird; Michael W Davidson; Elisabeth Schaffner-Reckinger; Christophe Ampe; Evelyne Friederich
Journal:  PLoS One       Date:  2015-10-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.